ES2054017T3 - Metodo para combatir pneumocystis carinii. - Google Patents
Metodo para combatir pneumocystis carinii.Info
- Publication number
- ES2054017T3 ES2054017T3 ES89309257T ES89309257T ES2054017T3 ES 2054017 T3 ES2054017 T3 ES 2054017T3 ES 89309257 T ES89309257 T ES 89309257T ES 89309257 T ES89309257 T ES 89309257T ES 2054017 T3 ES2054017 T3 ES 2054017T3
- Authority
- ES
- Spain
- Prior art keywords
- combat
- pneumocystis carinii
- carinii
- treatment
- pneuwocistis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
ESTA DESCRITO UN METODO PARA EL TRATAMIENTO DE PNEUWOCISTIS CARINII, AGENTE CAUSANTE DE LA NEUMONIA DE PARTICULAR GRAVEDAD PARA PACIENTES AFECTADOS CON EL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA) MEDIANTE LA ADMINISTRACION DE UN COMPONENTE CICLOHEXAPEPTIDO HIPOFILICO. LAS COMPOSICIONES APTAS PARA EL TRATAMIENTO DE P. CARINII TAMBIEN ESTAN DESCRITAS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24276788A | 1988-09-12 | 1988-09-12 | |
US24604288A | 1988-09-16 | 1988-09-16 | |
US39888989A | 1989-08-30 | 1989-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2054017T3 true ES2054017T3 (es) | 1994-08-01 |
Family
ID=27399603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89309257T Expired - Lifetime ES2054017T3 (es) | 1988-09-12 | 1989-09-12 | Metodo para combatir pneumocystis carinii. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0359529B1 (es) |
JP (1) | JPH0725692B2 (es) |
CA (1) | CA1333150C (es) |
DE (1) | DE68905119T2 (es) |
DK (1) | DK173802B1 (es) |
ES (1) | ES2054017T3 (es) |
IE (1) | IE892924L (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2020063A1 (en) * | 1989-06-30 | 1990-12-31 | Robert A. Giacobbe | Antibiotic agent |
GB8925593D0 (en) * | 1989-11-13 | 1990-01-04 | Fujisawa Pharmaceutical Co | Fr901379 substance and preparation thereof |
GB2241956A (en) * | 1990-03-16 | 1991-09-18 | Merck & Co Inc | N-acylated cyclohexapeptide compounds |
US5021403A (en) * | 1990-03-19 | 1991-06-04 | Merck & Co., Inc. | Antibiotic agents |
FI912873A (fi) * | 1990-06-18 | 1991-12-19 | Fujisawa Pharmaceutical Co | Ny polypeptidfoerening och foerfarande foer dess framstaellning. |
USH1638H (en) * | 1990-11-08 | 1997-03-04 | Furuta; Takahisa | Use of the polypeptide compound |
EP0486011A3 (en) * | 1990-11-16 | 1992-07-15 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical composition against pneumocystis carinii |
US5306708A (en) * | 1990-12-19 | 1994-04-26 | Merck & Co., Inc. | Antibiotic agent |
US5366880A (en) * | 1990-12-19 | 1994-11-22 | Merck & Co., Inc. | Antibiotic agent |
US5369093A (en) * | 1991-03-15 | 1994-11-29 | Merck & Co., Inc. | Lipopeptide derivatives |
TW199162B (es) * | 1991-05-09 | 1993-02-01 | Fujisawa Pharmaceutical Co | |
US6030944A (en) * | 1991-10-01 | 2000-02-29 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compounds |
ATE140460T1 (de) * | 1991-10-17 | 1996-08-15 | Merck & Co Inc | Echinocandin-b-derivat |
US5430018A (en) * | 1991-10-17 | 1995-07-04 | Merck & Co., Inc. | Cyclohexapeptide with basic nitrogen containing alkylamide groups |
US6384013B1 (en) | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5965525A (en) * | 1992-03-19 | 1999-10-12 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US6743777B1 (en) | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
GB9506372D0 (en) * | 1995-03-29 | 1995-05-17 | Fujisawa Pharmaceutical Co | New peptide compounds |
US5646111A (en) * | 1995-04-07 | 1997-07-08 | Eli Lilly And Company | Cyclic peptide antifungal Agents |
US5629290A (en) * | 1995-05-26 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5786325A (en) * | 1995-05-26 | 1998-07-28 | Eli Lilly And Company | Cyclic peptide antifungal agents and methods of making and using |
US5618787A (en) * | 1995-05-26 | 1997-04-08 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5652213A (en) * | 1995-05-26 | 1997-07-29 | Eli Lilly And Company | Cyclic peptide antifungal agents |
AU765660B2 (en) | 1998-08-20 | 2003-09-25 | Eli Lilly And Company | Ring modified cyclic peptide analogs |
BR9916101A (pt) | 1998-12-09 | 2002-06-04 | Lilly Co Eli | Purificação de compostos de ciclopeptìdeos equinocandinos |
DK1155034T3 (da) | 1999-03-03 | 2007-01-08 | Lilly Co Eli | Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte |
CA2362016A1 (en) | 1999-03-03 | 2000-09-08 | Kenneth Philip Moder | Echinocandin/carbohydrate complexes |
EP1582204B1 (en) | 1999-03-03 | 2013-09-25 | Eli Lilly & Company | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
KR20010112302A (ko) | 1999-03-03 | 2001-12-20 | 피터 지. 스트링거 | 제약학적 경구용 ecb 조제물 및 조성물의 제조 방법 |
US6991800B2 (en) | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2803581A1 (de) * | 1978-01-27 | 1979-08-02 | Sandoz Ag | Derivate des tetrahydro-echinocandin b |
CA1183127A (en) * | 1979-12-13 | 1985-02-26 | Manuel Debono | Process for the preparation of derivatives of cyclic peptide nuclei |
EP0311193B1 (en) * | 1987-10-07 | 1993-12-01 | Merck & Co. Inc. | Antifungal fermentation product |
US4968608A (en) * | 1987-10-07 | 1990-11-06 | Merck & Co., Inc. | Process for antifungal fermentation product |
-
1989
- 1989-09-11 DK DK198904463A patent/DK173802B1/da not_active IP Right Cessation
- 1989-09-12 EP EP89309257A patent/EP0359529B1/en not_active Expired - Lifetime
- 1989-09-12 IE IE892924A patent/IE892924L/xx unknown
- 1989-09-12 DE DE8989309257T patent/DE68905119T2/de not_active Expired - Fee Related
- 1989-09-12 ES ES89309257T patent/ES2054017T3/es not_active Expired - Lifetime
- 1989-09-12 CA CA000611139A patent/CA1333150C/en not_active Expired - Fee Related
- 1989-09-12 JP JP1236802A patent/JPH0725692B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK446389A (da) | 1990-03-13 |
EP0359529A1 (en) | 1990-03-21 |
DE68905119T2 (de) | 1993-08-26 |
IE892924L (en) | 1990-03-12 |
JPH0725692B2 (ja) | 1995-03-22 |
JPH02288837A (ja) | 1990-11-28 |
EP0359529B1 (en) | 1993-03-03 |
CA1333150C (en) | 1994-11-22 |
DK446389D0 (da) | 1989-09-11 |
DE68905119D1 (de) | 1993-04-08 |
DK173802B1 (da) | 2001-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2054017T3 (es) | Metodo para combatir pneumocystis carinii. | |
BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
ES2103262T3 (es) | Procedimiento de fotoestructuracion. | |
ES8201596A1 (es) | Procedimiento de obtencion de mucopolisacaridos | |
KR930023370A (ko) | 단백질 씨(c) 유도체 | |
KR890011606A (ko) | 항응고제 | |
NO990916D0 (no) | Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt | |
ATE72629T1 (de) | Cyclosporin enthaltende pharmazeutische zubereitung. | |
ATE81135T1 (de) | Aktive thymopentin-analoga. | |
ATE160941T1 (de) | Sulfatierte polysaccharide mit antimetastasenwirkung | |
ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
ES2146199T3 (es) | Utilizacion de la arginina como inmunoestimulante. | |
ES2061688T3 (es) | Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion. | |
ES2119165T3 (es) | Nueva actividad de cofactor anticoagulante. | |
ES2111163T3 (es) | Uso de fosfonatos para el tratamiento de la osteoporosis. | |
ES2057413T3 (es) | Agente antibiotico. | |
ES2174838T3 (es) | Metodo para aumentar la absorcion del intestino. | |
ES2055163T3 (es) | Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion. | |
ITRM910673A1 (it) | Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle. | |
IT8721691A0 (it) | Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali. | |
KR910001040A (ko) | 항응고요법을 위한 활성물질인 암블리옴민 | |
ES2145114T3 (es) | Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias. | |
ES2062120T3 (es) | Nuevas n-(aril substituido)-n'-(alcoxi substituido)-ureas y tioureas como agentes anticolesterolemicos y antiateroscleroticos. | |
SE7701441L (sv) | Nytt piperazinyluracilsalt | |
ES2076248T3 (es) | Dibenzofuranos substituidos y metodos para el uso de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 359529 Country of ref document: ES |